XML 135 R28.htm IDEA: XBRL DOCUMENT v3.25.1

Shareholders’ equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

Schedule of stock based compensation expense

The table below summarizes information about the Company’s stock-based compensation for the three months ended March 31, 2025 and 2024 and the expense recognized in the condensed consolidated statements of operations:

			Three Months Ended March 31,
			2025						2024
			(in thousands, except share and per share data)
Stock options
Options granted during period			3,943,722						3,738,800
Weighted average exercise price			$	3.31					$	2.40
Restricted stock units (RSUs)
Restricted stock units granted during period			901,900						1,316,200
Grant date fair value			$	3.29					$	2.40
Stock compensation expense
Research and development			$	555					$	1,041
General and administrative			738						973
Total stock compensation expense			$	1,293					$	2,014

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration